Cargando…
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death with a 5-year survival of only 21%. Reliable prognostic and/or predictive biomarkers are needed to improve NSCLC patient stratification, particularly in curative disease stages. Since the endogenous cannabinoid...
Autores principales: | Vidlarova, Monika, Berta, Emil, Prasil, Petr, Prokopova, Andrea, Gurska, Sona, Khoylou, Marta, Rehulkova, Alona, Kourilova, Pavla, Chudacek, Josef, Szkorupa, Marek, Klein, Jiri, Skarda, Jozef, Srovnal, Josef, Hajduch, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641041/ https://www.ncbi.nlm.nih.gov/pubmed/36386452 http://dx.doi.org/10.21037/tlcr-22-247 |
Ejemplares similares
-
Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery
por: Vecera, Lubomir, et al.
Publicado: (2023) -
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023) -
Recent Advances in Methods for Circulating Tumor Cell Detection
por: Vidlarova, Monika, et al.
Publicado: (2023) -
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling
por: Slavik, Hanus, et al.
Publicado: (2020) -
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
por: Slavik, Hanus, et al.
Publicado: (2022)